LightDeck Diagnostics Receives $2M for Development of Respiratory Illness Inflammation Test
LightDeck Diagnostics received a $2 million contract for the development of a rapid, quantitative, multiplexed test for inflammatory markers.
Read MorePosted by Andy Lundin | Jan 27, 2022 | Diagnostic Technologies, Respiratory Disease |
LightDeck Diagnostics received a $2 million contract for the development of a rapid, quantitative, multiplexed test for inflammatory markers.
Read MorePosted by Andy Lundin | Jan 26, 2022 | Covid 19, POC Reagents & Test Kits |
Researchers have developed a new test for COVID-19 that combines the speed of over-the-counter antigen tests with the accuracy of PCR tests.
Read MorePosted by Andy Lundin | Jan 25, 2022 | Covid 19 |
Staff shortages of medical laboratory professionals—an ongoing issue, despite the pandemic—is being exacerbated by booming cases of COVID infections.
Read MorePosted by Andy Lundin | Jan 25, 2022 | Covid 19, Flu & Respiratory Infections |
Compass Laboratory Services recently detected two cases of simultaneous infection by the SARS-CoV-2 virus and Influenza A.
Read MorePosted by Andy Lundin | Jan 25, 2022 | Covid 19 |
Researchers have identified factors that can be measured at the initial point of COVID-19 diagnosis that anticipate if a patient may develop long COVID.
Read More